Organogenesis Holdings Inc [ORGO] stock prices are up 2.04% to $3.00 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ORGO shares have gain 5.26% over the last week, with a monthly amount drifted -21.88%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 29, February 2024, Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance. In a post published today on Yahoo Finance, Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the fourth quarter and the year ended December 31, 2023.
From an analyst’s perspective:
Organogenesis Holdings Inc [NASDAQ: ORGO] stock has seen the most recent analyst activity on February 07, 2024, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $5. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on June 15, 2023, and set its price target to $5. On May 24, 2023, upgrade upgraded it’s rating to Buy but maintained its price target of $10 on the stock. BTIG Research downgraded its rating to a Neutral. Oppenheimer downgraded its rating to a Perform. SVB Leerink started tracking with a Outperform rating for this stock on January 10, 2020, and assigned it a price target of $9.
The stock price of Organogenesis Holdings Inc [ORGO] has been fluctuating between $1.79 and $4.70 over the past year. Organogenesis Holdings Inc [NASDAQ: ORGO] shares were valued at $3.00 at the most recent close of the market.
Analyzing the ORGO fundamentals
The Organogenesis Holdings Inc [NASDAQ:ORGO] reported sales of 433.14M for trailing twelve months, representing a drop of -13.73%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.92 points at the first support level, and at 2.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.06, and for the 2nd resistance point, it is at 3.12.
Organogenesis Holdings Inc [ORGO] reported earnings per share of $0 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.01/share, meaning a difference of -$0.01 and a surprise factor of -100.00%.
Ratios To Look Out For
It’s worth pointing out that Organogenesis Holdings Inc [NASDAQ:ORGO]’s Current Ratio is 2.80. In addition, the Quick Ratio stands at 2.44 and the Cash Ratio stands at 1.3. Considering the valuation of this stock, the price to sales ratio is 0.91, the price to book ratio is 1.41 and price to earnings (TTM) ratio is 81.74.
Transactions by insiders
Recent insider trading involved ERANI ALBERT, 10% Owner, that happened on Jan 10 ’24 when 17972.0 shares were sold. 10% Owner, ERANI ALBERT completed a deal on Jan 10 ’24 to sell 17972.0 shares. Meanwhile, 10% Owner ERANI ALBERT sold 0.2 million shares on Jan 09 ’24.
